Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04173364
PHASE3

Interscalene Block and Dysfunction Diaphragmatic

Sponsor: University Hospital, Lille

View on ClinicalTrials.gov

Summary

The study seeks to show that interscalene injection of a small volume (\<8ml) of ropivacaine at a low concentration (0.1%) reduces the frequency of hemi-diaphragmatic paresis compared to low volume injection at the standard concentration (0.5%) in patients undergoing arthroscopic shoulder surgery with ISB.

Official title: Interscalene Block and Dysfunction Diaphragmatic: Effect of Low Volume of Ropivacaine 0,1%. A Randomised, Controlled Trial

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2019-10-29

Completion Date

2020-09-21

Last Updated

2026-06-11

Healthy Volunteers

No

Interventions

DRUG

Ropivacaine 0.5% Injectable Solution

Injectable solution of ropivacaine 0.5%

DRUG

Ropivacaine 0.1% Injectable Solution

Dilution of ropivacaine to the concentration of 0.1%

Locations (1)

Hôpital Roger Salengro, CHU

Lille, France